EVALUATION OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO FIRST-GENERATION JANUS KINASE INHIBITORS

被引：0
|
作者：
Kamiya, M. [1 ]
Mori, S. [1 ]
Yamazaki, K. [1 ]
Togawa, D. [1 ]
机构：
[1] Kindai Univ, Nara Hosp, Dept Orthopaed & Rheumatol, Ikoma, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.650
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0670
引用
收藏
页码：608 / 608
页数：1
相关论文
共 50 条
  • [1] EFFICACY OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO FIRST GENERATION JAK INHIBITORS
    Kamiya, M.
    Mori, S.
    Yamazaki, K.
    Togawa, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [2] Characteristics and Treatment-selection in Patients with Rheumatoid Arthritis and with Inadequate Response to Janus Kinase Inhibitors
    Miyazaki, Yusuke
    Nakayamada, Shingo
    Kubo, Satoshi
    Sonomoto, Koshiro
    Inoue, Yoshino
    Fukuyo, Shunsuke
    Hanami, Kentaro
    Tanaka, Yoshiya
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 573 - 575
  • [3] Janus Kinase Inhibitors in Rheumatoid Arthritis: An Update on the Efficacy and Safety of Tofacitinib, Baricitinib and Upadacitinib
    Harrington, Robert
    Harkins, Patricia
    Conway, Richard
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [4] Janus kinase inhibitors for rheumatoid arthritis
    Yamaoka, Kunihiro
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2016, 32 : 29 - 33
  • [5] REAL-WORLD SINGLE CENTER USE OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS, INCLUDING THOSE REFRACTORY TO FIRST-GENERATION JAK INHIBITORS
    Kamiya, M.
    Mori, S.
    Yamazaki, K.
    Oka, N.
    Shoukaku, N.
    Togawa, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1430 - 1430
  • [6] Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany
    Tony, Hans-Peter
    Feist, Eugen
    Aries, Peer Malte
    Zinke, Silke
    Krueger, Klaus
    Ahlers, Jonas
    Albrecht, Inka
    Barrionuevo, Christian
    Kalus, Stefanie
    Burkhardt, Harald
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (01)
  • [7] Rapid Response with Upadacitinib Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to csDMARDs or bDMARDs
    FitzGerald, Oliver
    Rubbert-Roth, Andrea
    Chen, Kun
    Meenwein, Sebastian
    Enejosa, Jose Jeffrey
    Shaw, Tim
    Wells, Alvin F.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [8] RAPID RESPONSE WITH UPADACITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CSDMARDS OR BDMARDS
    FitzGerald, O.
    Rubbert-Roth, A.
    Chen, K.
    Meerwein, S.
    Enejosa, J.
    Shaw, T.
    Wells, A. F.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S53 - S53
  • [9] RAPID RESPONSE WITH UPADACITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CSDMARDS OR BDMARDS
    FitzGerald, O.
    Rubbert-Roth, A.
    Chen, K.
    Meerwein, S.
    Enejosa, J.
    Shaw, T.
    Wells, A. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 981 - 981
  • [10] Rapid Response With Upadacitinib Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to csDMARDs or bDMARDs
    FitzGerald, O.
    Rubbert-Roth, A.
    Chen, K.
    Meerwein, S.
    Enejosa, J.
    Shaw, T.
    Wells, A.
    SWISS MEDICAL WEEKLY, 2018, 148 : 22S - 22S
12345